Clinical trial · Interventional
Software Refraction With Mobilerone Versus Retinoscopy
Randomized Controlled Study on Subjective Refraction by Software Eye Test Technology Versus Retinoscopy
NCT06059521CI-TRIAL-00069988SRMRrecruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Software refraction in the mobilerone for myopia and astigmatism is a novel medical device for myopia adults and elder children with or without astigmatism. And the investigators would like to test its accuracy and efficacy as well as safety.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Astigmatism | — | UNRESOLVED | — |
| Myopia | — | UNRESOLVED | — |
| Myopia, Moderate | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Retinoscopy | Device | — | UNRESOLVED |
| Software refraction with Eye Test Technology in a mobilerone | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Software Refraction
- description
- Refraction is done by software with subjective refraction through a mobilerone.
- interventionNames
- Device: Software refraction with Eye Test Technology in a mobilerone
- type
- ACTIVE_COMPARATOR
- label
- Refraction by retinoscopy
- description
- Refraction is done objectively by retinoscopy.
- interventionNames
- Device: Retinoscopy
Primary outcomes (4)
- measure
- Spherical Equivalence(D)
- timeFrame
- 1-day and within 2 weeks
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 10 Years
- Maximum age
- 46 Years
Show eligibility criteria text
Inclusion Criteria: * • subject with ametropia on each eye ≤-12.00D * subject with best corrected visual acuity ≥ 20/25, no amblyopia * subject with normal transparency of eyes * subject with a healthy fundus that does not reveal major abnormalities that may affect vision due to the fluctuate situations * subject able to cooperate with the screen and the operator * subject without heavy drug treatment that may affect vision as synthetic antimalarials, corticosteroids * non-diabetic subject * non nystagmus subject * non-strabismus subject * subject who has not had eye surgery less than 1 year old Exclusion Criteria: * • subject with a topography showing an anomaly (keratoconus type or other) * subject with hyperopia or presbyopia * subject with mild myopia ≥ -1.00D * subject who cannot speak with the operator including those staff of local optometrists or ophthalmologists
References
Publications (0)
Data not yet available
No reference posted for this study.